HealthOncologists applaud melanoma data as Moderna shares tumble
Leaked results from a closely watched melanoma vaccine trial by Moderna and Merck drew praise from doctors, while Wall Street investors sold the companies’ shares—a rare divergence in reaction.
B
Bloomberg News★★★☆☆2026-10-23 20:00Original
Oncologists applaud melanoma data as Moderna shares tumble
Health